Compositions and methods for lipid production

US9896691B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9896691-B2
Application numberUS-201414268796-A
CountryUS
Kind codeB2
Filing dateMay 2, 2014
Priority dateMay 3, 2013
Publication dateFeb 20, 2018
Grant dateFeb 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein, inter alia, are compositions, oleagnious organisms, and methods useful for producing lipids, lipid precursors, and/or oleochemicals.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing a lipid, lipid precursor, or oleochemical comprising: a) culturing a genetically modified yeast cell in a growth medium; and b) isolating said lipid, lipid precursor, or oleochemical, wherein the dry weight of said genetically modified yeast cell comprises greater than 60% wt/wt lipids, lipid precursors, and oleochemicals; and wherein said genetically modified yeast cell comprises (i) a recombinant acyl-CoA:diacylglycerol acyltransferase 1 (DGA1) gene and a UGA2 succinate semialdehyde dehydrogenase (UGA2) gene comprising a mutation, wherein said mutation results in a loss of function of succinate semialdehyde dehydrogenase of 20% or more compared to succinate semialdehyde dehydrogenase encoded by UGA2 without the mutation; or (ii) a recombinant acyl-CoA:diacylglycerol acyltransferase 2 (DGA2) gene and a UGA2 succinate semialdehyde dehydrogenase (UGA2) gene comprising a mutation, wherein said mutation results in a loss of function of succinate semialdehyde dehydrogenase of 20% or more compared to succinate semialdehyde dehydrogenase encoded by UGA2 without the mutation. 2. The method of claim 1 , wherein said growth medium comprises a majority carbon source selected from the group consisting of glucose, glycerol, xylose, fructose, mannose, ribose, sucrose, and lignocellulosic biomass. 3. The method of claim 1 , wherein said growth medium comprises lignocellulosic biomass as the majority carbon source. 4. The method of claim 1 , wherein said growth medium comprises cobalt, iron, magnesium, potassium, zinc, nickel, molybdenum, manganese, copper, or boron. 5. The method of claim 1 , wherein said growth medium comprises 5.77×10 −5 M to 1.73×10 −4 M cobalt, 0.001 M to 0.003 M magnesium, 4.52×10 −5 M to 1.35×10 −4 M potassium, 4.05×10 −5 M to 1.22×10 −4 zinc, 3.55×10 −5 M to 1.06×10 −4 manganese, 9.07×10 −5 M to 2.91×10 −4 boron, 3.76×10 −5 M to 1.10×10 −5 molybdenum, 2.28×10 −5 M to 6.84×10 −5 nickel, 3.60×10 −5 M to 1.08×10 −4 iron, or 4.70×10 −5 M to 1.41×10 −4 copper. 6. The method of claim 1 , wherein said genetically modified yeast cell comprises a recombinant Lipid synthesis regulator (MGA2) gene, a genetically modified Lipid synthesis regulator (MGA2) gene, a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MFEI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene or a recombinant AMP Deaminase (AMPD) gene. 7. The method of claim 1 , wherein said genetically modified yeast cell comprises a genetically modified multifunctional enzyme (MFE1) gene and a genetically modified PEX10 Transcription Factor (PEX10) gene. 8. The method of claim 1 , wherein said genetically modified yeast cell comprises a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MFEI) gene and a genetically modified PEX10 Transcription Factor (PEX10) gene. 9. The method of claim 1 , wherein said genetically modified yeast cell comprises a genetically modified multifunctional enzyme (MFEI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene and a recombinant AMP Deaminase (AMPD) gene. 10. The method of claim 1 , wherein said genetically modified yeast cell comprises a recombinant Leucine Biosynthesis gene (LEU2), a genetically modified multifunctional enzyme (MFEI) gene, a genetically modified PEX10 Transcription Factor (PEX10) gene and a recombinant AMP Deaminase (AMPD)) gene.

Assignees

Inventors

Classifications

  • Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats · CPC title

  • Ligases (6) · CPC title

  • C12N15/815Primary

    for yeasts other than Saccharomyces · CPC title

  • acting on carbon to nitrogen bonds other than peptide bonds (3.5) · CPC title

  • Fatty acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9896691B2 cover?
Described herein, inter alia, are compositions, oleagnious organisms, and methods useful for producing lipids, lipid precursors, and/or oleochemicals.
Who is the assignee on this patent?
Univ Texas
What technology area does this patent fall under?
Primary CPC classification C12N15/815. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).